_id
69148831ccc777a4e85d9782
Ticker
ONTTF
Name
Oxford Nanopore Technologies Limited
Exchange
PINK
Address
Gosling Building, Oxford, United Kingdom, OX4 4DQ
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://nanoporetech.com
Description
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hardware, software, and chemistry. The company also provides PromethION 2 Solo, PromethION 2, PromethION 24, and PromethION 48. Its platform enables its customers to perform scientific/biomedical research in a various area, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. It operates in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.
Last Close
1.72
Volume
10000
Current Price
2.08
Change
0.28169014084507693
Last Updated
2026-01-05T12:11:35.884Z
Image
-
Ipo Date
-
Market Cap
1669995904
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.993
Sentiment Sources
1
Current Quarter
2025-06-30
Revenue
105600000
Cost Of Revenue
44200000
Gross Profit
61400000
Operating Expenses
139200000
Operating Income
-77800000
Interest Expense
-
Pretax Income
-69000000
Net Income
-71800000
Eps
-0.07494950478059415
Dividends Per Share
-
Shares Outstanding
966057025
Income Tax Expense
2800000
EBITDA
-66200000
Operating Margin
-73.67424242424242
Total Other Income Expense Net
8800000
Cash
194100000
Short Term Investments
137700000
Receivables
64800000
Inventories
95000000
Total Current Assets
507600000
Property Plant Equipment
97900000
Total Assets
671700000
Payables
95700000
Short Term Debt
5800000
Long Term Debt
-
Total Liabilities
148300000
Equity
523400000
Bs_currency_symbol
GBP
Depreciation
23000000
Change In Working Capital
-4400000
Cash From Operations
-48400000
Capital Expenditures
2400000
Cash From Investing
48700000
Cash From Financing
-3400000
Net Change In Cash
194100000
Cf_currency_symbol
-
PE
-
PB
3.8070211824226217
ROE
-13.717997707298432
ROA
-10.689295816584785
FCF
-50800000
Fcf Percent
-0.4810606060606061
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
3
Growth Investing Score
1.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
105600000
Quarters > 0 > income Statement > cost Of Revenue
44200000
Quarters > 0 > income Statement > gross Profit
61400000
Quarters > 0 > income Statement > operating Expenses
139200000
Quarters > 0 > income Statement > operating Income
-77800000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-69000000
Quarters > 0 > income Statement > net Income
-71800000
Quarters > 0 > income Statement > eps
-0.07494950478059415
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
957978311
Quarters > 0 > income Statement > income Tax Expense
2800000
Quarters > 0 > income Statement > EBITDA
-66200000
Quarters > 0 > income Statement > operating Margin
-73.67424242424242
Quarters > 0 > income Statement > total Other Income Expense Net
8800000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
194100000
Quarters > 0 > balance Sheet > short Term Investments
137700000
Quarters > 0 > balance Sheet > receivables
64800000
Quarters > 0 > balance Sheet > inventories
95000000
Quarters > 0 > balance Sheet > total Current Assets
507600000
Quarters > 0 > balance Sheet > property Plant Equipment
97900000
Quarters > 0 > balance Sheet > total Assets
671700000
Quarters > 0 > balance Sheet > payables
95700000
Quarters > 0 > balance Sheet > short Term Debt
5800000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
148300000
Quarters > 0 > balance Sheet > equity
523400000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-71800000
Quarters > 0 > cash Flow > depreciation
23000000
Quarters > 0 > cash Flow > change In Working Capital
-4400000
Quarters > 0 > cash Flow > cash From Operations
-48400000
Quarters > 0 > cash Flow > capital Expenditures
2400000
Quarters > 0 > cash Flow > cash From Investing
48700000
Quarters > 0 > cash Flow > cash From Financing
-3400000
Quarters > 0 > cash Flow > net Change In Cash
194100000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.07494950478059415
Quarters > 0 > ratios > PB
3.8070211824226217
Quarters > 0 > ratios > ROE
-13.717997707298432
Quarters > 0 > ratios > ROA
-10.689295816584785
Quarters > 0 > ratios > FCF
-50800000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.4810606060606061
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
99109000
Quarters > 1 > income Statement > cost Of Revenue
43176000
Quarters > 1 > income Statement > gross Profit
55933000
Quarters > 1 > income Statement > operating Expenses
131243000
Quarters > 1 > income Statement > operating Income
-75310000
Quarters > 1 > income Statement > interest Expense
1617000
Quarters > 1 > income Statement > pretax Income
-68605000
Quarters > 1 > income Statement > net Income
-71536000
Quarters > 1 > income Statement > eps
-0.07967953331888024
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
897796423
Quarters > 1 > income Statement > income Tax Expense
2931000
Quarters > 1 > income Statement > EBITDA
-60116000
Quarters > 1 > income Statement > operating Margin
-75.9870445670928
Quarters > 1 > income Statement > total Other Income Expense Net
6705000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
199517000
Quarters > 1 > balance Sheet > short Term Investments
138853000
Quarters > 1 > balance Sheet > receivables
44563000
Quarters > 1 > balance Sheet > inventories
99453000
Quarters > 1 > balance Sheet > total Current Assets
520095000
Quarters > 1 > balance Sheet > property Plant Equipment
101190000
Quarters > 1 > balance Sheet > total Assets
742050000
Quarters > 1 > balance Sheet > payables
31300000
Quarters > 1 > balance Sheet > short Term Debt
5358000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
155712000
Quarters > 1 > balance Sheet > equity
586338000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-65309000
Quarters > 1 > cash Flow > depreciation
23502000
Quarters > 1 > cash Flow > change In Working Capital
19118000
Quarters > 1 > cash Flow > cash From Operations
-49914000
Quarters > 1 > cash Flow > capital Expenditures
28513000
Quarters > 1 > cash Flow > cash From Investing
10700000
Quarters > 1 > cash Flow > cash From Financing
75550000
Quarters > 1 > cash Flow > net Change In Cash
37500000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.07967953331888024
Quarters > 1 > ratios > PB
3.184880665827561
Quarters > 1 > ratios > ROE
-12.200471400455028
Quarters > 1 > ratios > ROA
-9.640320733104238
Quarters > 1 > ratios > FCF
-78427000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.7913206671442553
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
84082000
Quarters > 2 > income Statement > cost Of Revenue
34620000
Quarters > 2 > income Statement > gross Profit
49462000
Quarters > 2 > income Statement > operating Expenses
126485000
Quarters > 2 > income Statement > operating Income
-77023000
Quarters > 2 > income Statement > interest Expense
1948000
Quarters > 2 > income Statement > pretax Income
-71356000
Quarters > 2 > income Statement > net Income
-74652000
Quarters > 2 > income Statement > eps
-0.08664782927165772
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
861556494
Quarters > 2 > income Statement > income Tax Expense
3296000
Quarters > 2 > income Statement > EBITDA
-62659000
Quarters > 2 > income Statement > operating Margin
-91.6046240574677
Quarters > 2 > income Statement > total Other Income Expense Net
5667000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
162017000
Quarters > 2 > balance Sheet > short Term Investments
96936000
Quarters > 2 > balance Sheet > receivables
61059000
Quarters > 2 > balance Sheet > inventories
108024000
Quarters > 2 > balance Sheet > total Current Assets
441741000
Quarters > 2 > balance Sheet > property Plant Equipment
93045000
Quarters > 2 > balance Sheet > total Assets
722653000
Quarters > 2 > balance Sheet > payables
90569000
Quarters > 2 > balance Sheet > short Term Debt
5126000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
144073000
Quarters > 2 > balance Sheet > equity
578580000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-74652000
Quarters > 2 > cash Flow > depreciation
19782000
Quarters > 2 > cash Flow > change In Working Capital
-20948000
Quarters > 2 > cash Flow > cash From Operations
-59971000
Quarters > 2 > cash Flow > capital Expenditures
20123000
Quarters > 2 > cash Flow > cash From Investing
4327000
Quarters > 2 > cash Flow > cash From Financing
-1969000
Quarters > 2 > cash Flow > net Change In Cash
-58519000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.08664782927165772
Quarters > 2 > ratios > PB
3.0973028924608523
Quarters > 2 > ratios > ROE
-12.902623664834595
Quarters > 2 > ratios > ROA
-10.33026916099428
Quarters > 2 > ratios > FCF
-80094000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.9525701101305868
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
83666000
Quarters > 3 > income Statement > cost Of Revenue
42732000
Quarters > 3 > income Statement > gross Profit
40934000
Quarters > 3 > income Statement > operating Expenses
134759000
Quarters > 3 > income Statement > operating Income
-93825000
Quarters > 3 > income Statement > interest Expense
1137000
Quarters > 3 > income Statement > pretax Income
-83209000
Quarters > 3 > income Statement > net Income
-84408000
Quarters > 3 > income Statement > eps
-0.10224202424847034
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
825570509
Quarters > 3 > income Statement > income Tax Expense
1199000
Quarters > 3 > income Statement > EBITDA
-72640000
Quarters > 3 > income Statement > operating Margin
-112.14232782731337
Quarters > 3 > income Statement > total Other Income Expense Net
10616000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
220536000
Quarters > 3 > balance Sheet > short Term Investments
49514000
Quarters > 3 > balance Sheet > receivables
42326000
Quarters > 3 > balance Sheet > inventories
101548000
Quarters > 3 > balance Sheet > total Current Assets
447183000
Quarters > 3 > balance Sheet > property Plant Equipment
82416000
Quarters > 3 > balance Sheet > total Assets
777062000
Quarters > 3 > balance Sheet > payables
25184000
Quarters > 3 > balance Sheet > short Term Debt
4322000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
133211000
Quarters > 3 > balance Sheet > equity
643851000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-84408000
Quarters > 3 > cash Flow > depreciation
21758000
Quarters > 3 > cash Flow > change In Working Capital
-25824000
Quarters > 3 > cash Flow > cash From Operations
-78717000
Quarters > 3 > cash Flow > capital Expenditures
4334000
Quarters > 3 > cash Flow > cash From Investing
-101216000
Quarters > 3 > cash Flow > cash From Financing
66615000
Quarters > 3 > cash Flow > net Change In Cash
-114276000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.10224202424847034
Quarters > 3 > ratios > PB
2.6670559783552403
Quarters > 3 > ratios > ROE
-13.109865481299247
Quarters > 3 > ratios > ROA
-10.862453703822862
Quarters > 3 > ratios > FCF
-83051000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.9926493438194727
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
183191000
Annuals > 0 > income Statement > cost Of Revenue
77796000
Annuals > 0 > income Statement > gross Profit
105395000
Annuals > 0 > income Statement > operating Expenses
257728000
Annuals > 0 > income Statement > operating Income
-152333000
Annuals > 0 > income Statement > interest Expense
3565000
Annuals > 0 > income Statement > pretax Income
-139961000
Annuals > 0 > income Statement > net Income
-146188000
Annuals > 0 > income Statement > eps
-0.1628297866363854
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
897796423
Annuals > 0 > income Statement > income Tax Expense
6227000
Annuals > 0 > income Statement > EBITDA
-93112000
Annuals > 0 > income Statement > operating Margin
-83.15528601295915
Annuals > 0 > income Statement > total Other Income Expense Net
12372000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
199517000
Annuals > 0 > balance Sheet > short Term Investments
138853000
Annuals > 0 > balance Sheet > receivables
44563000
Annuals > 0 > balance Sheet > inventories
99453000
Annuals > 0 > balance Sheet > total Current Assets
520095000
Annuals > 0 > balance Sheet > property Plant Equipment
101190000
Annuals > 0 > balance Sheet > total Assets
742050000
Annuals > 0 > balance Sheet > payables
31300000
Annuals > 0 > balance Sheet > short Term Debt
5358000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
155712000
Annuals > 0 > balance Sheet > equity
586338000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-139961000
Annuals > 0 > cash Flow > depreciation
43284000
Annuals > 0 > cash Flow > change In Working Capital
-1830000
Annuals > 0 > cash Flow > cash From Operations
-109885000
Annuals > 0 > cash Flow > capital Expenditures
48636000
Annuals > 0 > cash Flow > cash From Investing
15027000
Annuals > 0 > cash Flow > cash From Financing
73581000
Annuals > 0 > cash Flow > net Change In Cash
-21019000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.1628297866363854
Annuals > 0 > ratios > PB
2.633651319818944
Annuals > 0 > ratios > ROE
-24.932376888415895
Annuals > 0 > ratios > ROA
-19.70055926150529
Annuals > 0 > ratios > FCF
-158521000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.8653318121523438
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
169668000
Annuals > 1 > income Statement > cost Of Revenue
79187000
Annuals > 1 > income Statement > gross Profit
90481000
Annuals > 1 > income Statement > operating Expenses
259090000
Annuals > 1 > income Statement > operating Income
-168609000
Annuals > 1 > income Statement > interest Expense
2206000
Annuals > 1 > income Statement > pretax Income
-149768000
Annuals > 1 > income Statement > net Income
-154507000
Annuals > 1 > income Statement > eps
-0.18526899812185077
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
833960358
Annuals > 1 > income Statement > income Tax Expense
4739000
Annuals > 1 > income Statement > EBITDA
-105935000
Annuals > 1 > income Statement > operating Margin
-99.3758398755216
Annuals > 1 > income Statement > total Other Income Expense Net
18841000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
220536000
Annuals > 1 > balance Sheet > short Term Investments
49514000
Annuals > 1 > balance Sheet > receivables
42326000
Annuals > 1 > balance Sheet > inventories
101548000
Annuals > 1 > balance Sheet > total Current Assets
447183000
Annuals > 1 > balance Sheet > property Plant Equipment
82416000
Annuals > 1 > balance Sheet > total Assets
777062000
Annuals > 1 > balance Sheet > payables
25184000
Annuals > 1 > balance Sheet > short Term Debt
4322000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
133211000
Annuals > 1 > balance Sheet > equity
643851000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-149768000
Annuals > 1 > cash Flow > depreciation
41627000
Annuals > 1 > cash Flow > change In Working Capital
-41440000
Annuals > 1 > cash Flow > cash From Operations
-137302000
Annuals > 1 > cash Flow > capital Expenditures
27290000
Annuals > 1 > cash Flow > cash From Investing
-61794000
Annuals > 1 > cash Flow > cash From Financing
64734000
Annuals > 1 > cash Flow > net Change In Cash
-136242000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.18526899812185077
Annuals > 1 > ratios > PB
2.2278629927731726
Annuals > 1 > ratios > ROE
-23.997322361850802
Annuals > 1 > ratios > ROA
-19.883484200745887
Annuals > 1 > ratios > FCF
-164592000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.9700827498408657
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
198603000
Annuals > 2 > income Statement > cost Of Revenue
74793000
Annuals > 2 > income Statement > gross Profit
123810000
Annuals > 2 > income Statement > operating Expenses
222289000
Annuals > 2 > income Statement > operating Income
-98479000
Annuals > 2 > income Statement > interest Expense
1628000
Annuals > 2 > income Statement > pretax Income
-83411000
Annuals > 2 > income Statement > net Income
-91025000
Annuals > 2 > income Statement > eps
-0.11050173677470448
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
823742709
Annuals > 2 > income Statement > income Tax Expense
7614000
Annuals > 2 > income Statement > EBITDA
-65765000
Annuals > 2 > income Statement > operating Margin
-49.58585721263022
Annuals > 2 > income Statement > total Other Income Expense Net
15068000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
356778000
Annuals > 2 > balance Sheet > short Term Investments
119411000
Annuals > 2 > balance Sheet > receivables
41181000
Annuals > 2 > balance Sheet > inventories
87698000
Annuals > 2 > balance Sheet > total Current Assets
638000000
Annuals > 2 > balance Sheet > property Plant Equipment
63200000
Annuals > 2 > balance Sheet > total Assets
823890000
Annuals > 2 > balance Sheet > payables
23103000
Annuals > 2 > balance Sheet > short Term Debt
4056000
Annuals > 2 > balance Sheet > long Term Debt
0
Annuals > 2 > balance Sheet > total Liabilities
130334000
Annuals > 2 > balance Sheet > equity
693556000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-83411000
Annuals > 2 > cash Flow > depreciation
31871000
Annuals > 2 > cash Flow > change In Working Capital
-27685000
Annuals > 2 > cash Flow > cash From Operations
-49387000
Annuals > 2 > cash Flow > capital Expenditures
42234000
Annuals > 2 > cash Flow > cash From Investing
-65794000
Annuals > 2 > cash Flow > cash From Financing
-13715000
Annuals > 2 > cash Flow > net Change In Cash
-131062000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.11050173677470448
Annuals > 2 > ratios > PB
2.0428594943739222
Annuals > 2 > ratios > ROE
-13.124390820640293
Annuals > 2 > ratios > ROA
-11.048198181796113
Annuals > 2 > ratios > FCF
-91621000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.4613273716912635
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
133661000
Annuals > 3 > income Statement > cost Of Revenue
60466000
Annuals > 3 > income Statement > gross Profit
73195000
Annuals > 3 > income Statement > operating Expenses
237728000
Annuals > 3 > income Statement > operating Income
-164533000
Annuals > 3 > income Statement > interest Expense
908000
Annuals > 3 > income Statement > pretax Income
-166004000
Annuals > 3 > income Statement > net Income
-167613000
Annuals > 3 > income Statement > eps
-0.20401855014320133
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
821557647
Annuals > 3 > income Statement > income Tax Expense
1609000
Annuals > 3 > income Statement > EBITDA
-140405000
Annuals > 3 > income Statement > operating Margin
-123.09723853629706
Annuals > 3 > income Statement > total Other Income Expense Net
-1471000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
487840000
Annuals > 3 > balance Sheet > short Term Investments
130628000
Annuals > 3 > balance Sheet > receivables
38473000
Annuals > 3 > balance Sheet > inventories
63071000
Annuals > 3 > balance Sheet > total Current Assets
750609000
Annuals > 3 > balance Sheet > property Plant Equipment
61919000
Annuals > 3 > balance Sheet > total Assets
841866000
Annuals > 3 > balance Sheet > payables
20486000
Annuals > 3 > balance Sheet > short Term Debt
2610000
Annuals > 3 > balance Sheet > long Term Debt
9500000
Annuals > 3 > balance Sheet > total Liabilities
137890000
Annuals > 3 > balance Sheet > equity
703976000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-166004000
Annuals > 3 > cash Flow > depreciation
24691000
Annuals > 3 > cash Flow > change In Working Capital
17015000
Annuals > 3 > cash Flow > cash From Operations
-53826000
Annuals > 3 > cash Flow > capital Expenditures
30817000
Annuals > 3 > cash Flow > cash From Investing
-161985000
Annuals > 3 > cash Flow > cash From Financing
622905000
Annuals > 3 > cash Flow > net Change In Cash
406977000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.20401855014320133
Annuals > 3 > ratios > PB
2.0072831358455403
Annuals > 3 > ratios > ROE
-23.809476459424754
Annuals > 3 > ratios > ROA
-19.90970059368118
Annuals > 3 > ratios > FCF
-84643000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-0.6332662481950606
Annuals > 3 > health Score
35
Valuation > metrics > PE
-0.07494950478059415
Valuation > metrics > PB
3.8070211824226217
Valuation > final Score
41.92978817577378
Valuation > verdict
26.9% Overvalued
Profitability > metrics > ROE
-13.717997707298432
Profitability > metrics > ROA
-14.144996059889678
Profitability > metrics > Net Margin
-0.6799242424242424
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.2833397019487963
Risk > metrics > Interest Coverage
-27.785714285714285
Risk > final Score
-51
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.000985221674877
Liquidity > metrics > Quick Ratio
4.065024630541872
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
48.151193341724394
Prev Valuations > 1
49.02697107539148
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-126
Prev Risks > 1
-98
Prev Risks > 2
-270
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:20:48.906Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-02
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hardware, software, and chemistry. The company also provides PromethION 2 Solo, PromethION 2, PromethION 24, and PromethION 48. Its platform enables its customers to perform scientific/biomedical research in a various area, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. It operates in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AStifel upgrades Oxford Nanopore stock rating to Hold on strong growth - Investing.com Nigeria
1/8/2026
Stifel upgrades Oxford Nanopore stock rating to Hold on strong growth Investing.com Nigeria
Read more →Oxford Nanopore Technologies (OTC:ONTTF) Shares Down 1.7% – Should You Sell? - Defense World
1/1/2026
Oxford Nanopore Technologies (OTC:ONTTF) Shares Down 1.7% – Should You Sell? Defense World
Read more →Showing 2 of 8
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Oxford Nanopore Technologies Limited
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.